Effector Therapeutics Inc. logo

Effector Therapeutics Inc. Share Price EFTR

Last updated on

Check the interactive Effector Therapeutics Inc. Stock chart to analyse performance

Effector Therapeutics Inc. Key Stats

Check Effector Therapeutics Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.0E-4
Open
$6.0E-4
Market Capitalization
$2.4K
Today's Volume
$4.0K
Revenue TTM
$675.0K
EBITDA
$-32.6M
Earnings Per Share (EPS)
$-12.57
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-946.56%

Stock Returns calculator for Effector Therapeutics Inc. Stock including INR - Dollar returns

The Effector Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Effector Therapeutics Inc. investment value today

Current value as on today

Returns

(0%)

Returns from Effector Therapeutics Inc. Stock

(0%)

Dollar Impact

(0%)

Global Institutional Holdings in Effector Therapeutics Inc.

  • Name

    Holdings %

  • Sabby Management LLC

    7.48%

  • The Carlyle Group Inc

    4.10%

  • UBS Group AG

    1.31%

  • Geode Capital Management, LLC

    0.54%

  • Vanguard Group Inc

    0.53%

  • HRT FINANCIAL LLC

    0.46%

Analyst Recommendation on Effector Therapeutics Inc. Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Effector Therapeutics Inc.(by analysts ranked 0 to 5 stars)

About Effector Therapeutics Inc.

eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. The company's lead product candidates comprise Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer; and Zotatifin, a small molecule inhibitor of eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors, as well as completed Phase 2a open-label expansion cohort in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. The company has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E; and collaboration agreement with the Dana-Farber Cancer Institute on a Phase 2 clinical trial, evaluating Zotatifin as combination treatment in ER+ endometrial cancer and in low grade serous ovarian cancer. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.
Organization
Effector Therapeutics Inc.
Employees
14
CEO
Mr. Craig R. Jalbert CIRA
Industry
Miscellaneous

Important FAQs about investing in EFTR Stock from India :

What is Effector Therapeutics Inc. share price today?

Effector Therapeutics Inc. share price today is as on at the close of the market. Effector Therapeutics Inc. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Effector Therapeutics Inc. share?

Effector Therapeutics Inc. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Effector Therapeutics Inc. stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Effector Therapeutics Inc. Stock (EFTR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Effector Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Effector Therapeutics Inc. Shares .

What is the minimum amount required to buy Effector Therapeutics Inc. Stock (EFTR) from India?

Indian investors can start investing in Effector Therapeutics Inc. (EFTR) shares with as little as ₹95.7913 or $1 (as of May 13, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹957.91 in Effector Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on May 13, 2026). Learn more about fractional shares .

What are the returns that Effector Therapeutics Inc. has given to Indian investors in the last 5 years?

Effector Therapeutics Inc. stock has given -100.0% share price returns and 30.68% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?